MBF Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- MBF Therapeutics's estimated annual revenue is currently $3.1M per year.
- MBF Therapeutics's estimated revenue per employee is $155,000
Employee Data
- MBF Therapeutics has 20 Employees.
- MBF Therapeutics grew their employee count by 11% last year.
MBF Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & President | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | CSO | Reveal Email/Phone |
MBF Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is MBF Therapeutics?
MBF Therapeutics is a life science company developing and commercializing proprietary checkpoint inhibitor immunotherapy technology for cancer and infectious diseases in both animal and human health. T-cell activation precisely targets selected antigens associated with cancer cells or infectious pathogens while preventing T-cell exhaustion, thus, yielding a durable cell-mediated immunity. MBF Therapeutics has in-licensed checkpoint inhibitor technology from several sources. In addition, MBF Therapeutics has discovered novel proprietary immunomodulating technology. These combined with a proprietary nonviral delivery system (CaptaVaxâ„¢), in-licensed from the Southwest Research Institute, provides MBF Therapeutics with a powerful platform technology from which multiple innovative products can be developed for veterinary medicine and human health where cellular antigens are well defined.
keywords:N/A
N/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.9M | 20 | 0% | N/A |
#2 | $4.5M | 20 | -23% | N/A |
#3 | $2.9M | 20 | -20% | N/A |
#4 | $3.5M | 20 | 5% | N/A |
#5 | $2M | 20 | N/A | N/A |